Total Medical devices industry deals worth $4.29bn were announced globally for April 2022, with the ArchiMed $1.2bn private equity deal with Natus Medical being the sector’s biggest investment, according to GlobalData’s deals database.
Go deeper with GlobalData
- Embed this chart
Embed this chart into your website
Copy and paste the image source into your website to display the chart.
The value marked an increase of 39.3% over the previous month of $3.08bn and a drop of 73.2% when compared with the last 12-month average of $16bn.
In terms of number of deals, the sector saw a drop of 21.89% with 157 deals in April 2022 when compared to the last 12-month average of 201 deals.
In value terms, North America led the activity with deals worth $2.8bn in April 2022.
Medical devices industry deals in April 2022: Top deals
The top five deals accounted for 56.7% of the overall value during April 2022.
The combined value of the top five deals stood at $2.43bn, against the overall value of $4.3bn recorded for the month.
The top five Medical devices industry deals of April 2022 tracked by GlobalData were:
1) ArchiMed $1.2bn private equity deal with Natus Medical
2) The $541.63m acquisition of Phenox by Wallaby Medical
3) CVS Health,Export Development Bank of Iran,General Atlantic,Mass Mutual Ventures,Openspace Ventures,Sequoia Capital and SoftBank Vision Fund II $300m venture financing deal with Biofourmis
4) The $220m venture financing of Reify Health by Adams Street Partners,Altimeter Capital Management,Battery Ventures,Coatue,Dragoneer Investment Group and ICONIQ Growth
5) Fulgent Genetics $170m acquisition deal with Inform Diagnostics
